iDEL Therapeutics
PrivateLast Round
Seed
Mar 17, 2026
Total Funding Raised
$21.05M
Company Overview
iDEL Therapeutics is a biotechnology company developing a pipeline of cancer therapeutics that are delivered directly into the cytosol of tumor cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iDEL Therapeutics Comps
Public and private peers based on sector, stage, and business model.
iDEL Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 17, 2026 | ||||
| Seed | Mar 17, 2026 |
iDEL Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NRW.Venture | Seed |
| KHAN Technology Transfer Fund II | Seed |
| BioMedPartners | Seed |
| Gründerfonds Ruhr | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 17, 2026
$11M raised in Seed round.
iDEL Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about iDEL Therapeutics's valuation, stock price, and market status.
